CoChat

Add-on Therapy of EPA Reduces Oxidative Stress and Inhibits the Progression of Aortic Stiffness in Patients with Coronary Artery Disease and Statin Therapy: A Randomized Controlled Study

Open access
Takaki, Akira, Umemoto, Seiji, Ono, Kaoru, Seki, Kouzaburo, Ryoke, Tsutomu, Fujii, Akihisa, Itagaki, Tatsunori, Harada, Masahiko, Tanaka, Masakazu, Yonezawa, Takahito, Ogawa, Hiroshi, Matsuzaki, Masunori · 2011 · Journal of Atherosclerosis and Thrombosis
Cited by 41

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Abstract

AIM: We examined the anti-oxidant mechanisms of combined therapy of eicosapentaenoic acid (EPA) plus statin on the progression of atherosclerosis. METHODS: Patients receiving statin therapy for dyslipidemia and with coronary artery disease (CAD) were assigned randomly in an open-label manner to the EPA (1,800 mg/day) -plus-statin group (n= 25; combined-therapy group) or to the statin-only group (n= 25), and followed for 48 weeks. At baseline and 48 weeks after enrollment, oxidative stress, brachial-ankle pulse wave velocity (baPWV) and stiffness parameter β-index of the carotid were measured. RESULTS: The lipid profile remained unchanged throughout the study. Although the median value of baPWV increased more in the statin-only group than in the combined-therapy group, this difference was not significant (p= 0.29); however, a decrease in baPWV was associated with combined-therapy treatment by multiple regression analysis adjusted for age and mean blood pressure (p= 0.04). In addition, the β-index of the carotid was lower in the combined-therapy group than in the statin-only group (p= 0.02). Furthermore, although the difference in the reduction of the urinary concentration of 8-isoprostane between the two groups did not reach statistical significance, this concentration was significantly lower in the combined-therapy group with higher baseline levels (≥ 183 pg/mL · Cr) of urinary 8-isoprostane (p= 0.004). CONCLUSIONS: EPA may reduce oxidative stress and inhibit the progression of arterial stiffness more efficiently than statin-only therapy in patients with dyslipidemia and CAD.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.5551/jat.7260

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Research works printed but not linked: 34

  1. 10.1016/S0140-6736(05)67394-1 · DOI · Paper page
  2. 3) Sharma RK, Singh VN, Reddy HK: Thinking beyond low-density lipoprotein cholesterol: Strategies to further reduce cardiovascular risk. Vasc Health Risk Manag, 2009; 5: 793-799 · DOI
  3. 4) Lee JH, O' Keefe JH, Lavie CJ, Harris WS: Omega-3 fatty acids: Cardiovascular benefits, sources and sustainability. Nat Rev Cardiol, 2009; 6: 753-758 · DOI · Paper page
  4. 5) Jacobson TA: Beyond lipids: The role of omega-3 fatty acids from fish oil in the prevention of coronary heart disease. Curr Atheroscler Rep, 2007; 9: 145-153 · DOI
  5. 10.1253/circj.CJ-08-1197 · DOI · Paper page
  6. 9) Cecelja M, Chowienczyk P: Dissociation of aortic pulse wave velocity with risk factors for cardiovascular disease other than hypertension: A systematic review. Hypertension, 2009; 54: 1328-1336 · DOI · Paper page
  7. 10) Inoue N, Maeda R, Kawakami H, Shokawa T, Yamamoto H, Ito C, Sasaki H: Aortic pulse wave velocity predicts cardiovascular mortality in middle-aged and elderly japanese men. Circ J, 2009; 73: 549-553 · DOI
  8. 10.1161/ATVBAHA.109.196980 · DOI · Paper page
  9. 10.5551/jat.E605 · DOI
  10. 10.1016/S0002-9149(02)02226-9 · DOI
  11. 10.1161/01.CIR.0000015607.33345.1F · doi:10.1161/01.cir.0000015607.33345.1f
  12. 15) Umeji K, Umemoto S, Itoh S, Tanaka M, Kawahara S, Fukai T, Matsuzaki M: Comparative effects of pitavastatin and probucol on oxidative stress, Cu/Zn superoxide dismutase, PPAR-gamma, and aortic stiffness in hypercholesterolemia. Am J Physiol Heart Circ Physiol, 2006; 291: H2522-2532 · DOI
  13. 10.1291/hypres.25.359 · DOI · Paper page
  14. 10.1291/hypres.27.851 · DOI
  15. 10.1016/S0895-7061(03)00918-X · DOI · Paper page
  16. 19) Hirai T, Sasayama S, Kawasaki T, Yagi S: Stiffness of systemic arteries in patients with myocardial infarction. A noninvasive method to predict severity of coronary atherosclerosis. Circulation, 1989; 80: 78-86 · DOI · Paper page
  17. 20) O' Leary DH, Polak JF, Kronmal RA, Manolio TA, Burke GL, Wolfson SK Jr: Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular health study collaborative research group. N Engl J Med, 1999; 340: 14-22
  18. 10.1016/j.jjcc.2008.09.010 · DOI
  19. 10.1016/0003-2697(84)90467-6 · DOI · Paper page
  20. 10.1016/0049-3848(84)90248-2 · DOI
  21. 10.5551/jat.2618 · DOI · Paper page
  22. 25) Origasa H, Yokoyama M, Matsuzaki M, Saito Y, Matsuzawa Y: Clinical importance of adherence to treatment with eicosapentaenoic acid by patients with hypercholesterolemia. Circ J, 2010; 74: 510-517 · DOI · Paper page
  23. 10.5551/jat.3616 · DOI
  24. 27) Wang KL, Cheng HM, Sung SH, Chuang SY, Li CH, Spurgeon HA, Ting CT, Najjar SS, Lakatta EG, Yin FC, Chou P, Chen CH: Wave reflection and arterial stiffness in the prediction of 15-year all-cause and cardiovascular mortalities: A community-based study. Hypertension, 2010; 55: 799-805 · DOI · Paper page
  25. 10.1291/hypres.28.651 · DOI
  26. 10.1038/hr.2009.145 · DOI
  27. 10.1161/01.CIR.0000093660.86242.BB · DOI · Paper page
  28. 10.1161/01.CIR.0000093661.90582.c4 · DOI · Paper page
  29. 10.1253/jcj.60.691 · DOI
  30. 33) Hironaka K, Yano M, Kohno M, Tanigawa T, Obayashi M, Konishi M, Umemoto S, Matsuzaki M: In vivo aortic wall characteristics at the early stage of atherosclerosis in rabbits. Am J Physiol, 1997; 273: H1142-1147 · DOI
  31. 10.1016/S0163-7827(97)00001-5 · DOI · Paper page
  32. 35) Nakamura N, Hamazaki T, Ohta M, Okuda K, Urakaze M, Sawazaki S, Yamazaki K, Satoh A, Temaru R, Ishikura Y, Takata M, Kishida M, Kobayashi M: Joint effects of HMG-CoA reductase inhibitors and eicosapentaenoic acids on serum lipid profile and plasma fatty acid concentrations in patients with hyperlipidemia. Int J Clin Lab Res, 1999; 29: 22-25 · DOI
  33. 36) Burns T, Maciejewski SR, Hamilton WR, Zheng M, Mooss AN, Hilleman DE: Effect of omega-3 fatty acid supplementation on the arachidonic acid: Eicosapentaenoic acid ratio. Pharmacotherapy, 2007; 27: 633-638 · DOI
  34. 10.5551/jat.281 · DOI

Cited by

Metadata

Authors
Takaki, A., Umemoto, S., Ono, K., Seki, K., Ryoke, T., Fujii, A., Itagaki, T., Harada, M., Tanaka, M., Yonezawa, T., Ogawa, H., & Matsuzaki, M.
Venue
Journal of Atherosclerosis and Thrombosis
Published
2011
Volume
18
Issue
10
Pages
857-866
ISSN
  • 1340-3478 (ISSN-L)
  • 1880-3873
OpenAlex
W2082820286
Cited by
41
References
4
FWCI
1.64
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.